Treprostinil

FDA Approved: * November 30, 2017
Pharm Company: * SANDOZ INC
Category: Blood Pressure

Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation, is a vasodilator that is used for the treatment of pulmonary arterial hypertension.[1] Treprostinil is a synthetic analog of prostacyclin (PGI2). Treprostinil was approved for use in the United States in May 2002.[2] The drug can be given in various forms: IV, subcutaneous injection, oral inhalation, as well as oral extended-release tablets. The subc... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.